CVE:IGX

IntelGenx Technologies Corp. (IGX.V) Stock Forecast, Price & News

C$0.32

+0.01 (+1.56 %)

(As of 01/22/2021 02:16 PM ET)

Add

Compare

Today's Range

C$0.32

Now: C$0.33▼

C$0.33

50-Day Range

C$0.00

MA: C$0.31▼

C$0.39

52-Week Range

C$0.16

Now: C$0.33▼

C$0.62

Volume14,197 shs

Average Volume29,137 shs

Market CapitalizationC$35.83 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

IntelGenx Technologies Corp., a drug delivery company, focuses on the development of novel oral thin film products for the pharmaceutical market. It offers RIZAPORT, an oral thin film formulation of rizatriptan benzoate for the treatment of acute migraines. The company's products under development comprise INT0004/2006, an antidepressant; INT0046/2018 for adult use; INT0007/2006 for the treatment of erectile dysfunction; INT0008/2008 for migraine; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid dependence; INT0036/2013 for schizophrenia; and INT0043/2015 to treat Alzheimer's disease. It is also developing INT0037/2013, INT0039/2013, and INT0040/2014. The company has co-development and commercialization agreements with RedHill Biopharma Ltd., Par Pharmaceutical Companies, Inc., and Endo Ventures Ltd.; licensing, development, and supply agreement with Tilray, Inc., Gensco Pharma, and Insud Pharma; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.

Overall MarketRank^™

0.52 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for IntelGenx Technologies Corp. (IGX.V).

2.6 Community Rank

Outperform Votes
IntelGenx Technologies Corp. (IGX.V) has received 92 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
IntelGenx Technologies Corp. (IGX.V) has received 86 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
IntelGenx Technologies Corp. (IGX.V) has received 51.69% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about IntelGenx Technologies Corp. (IGX.V) and other stocks. Vote “Outperform” if you believe IGX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe IGX will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
IntelGenx Technologies Corp. (IGX.V) does not currently pay a dividend.
Dividend Growth
IntelGenx Technologies Corp. (IGX.V) does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, IntelGenx Technologies Corp. (IGX.V) insiders have sold more of their company's stock than they have bought. Specifically, they have bought C$0.00 in company stock and sold C$155.00 in company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of IntelGenx Technologies Corp. (IGX.V) is -4.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of IntelGenx Technologies Corp. (IGX.V) is -4.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange CVE

Industry Biotechnology

Sub-IndustryN/A

SectorMedical

Current SymbolCVE:IGX

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.intelgenx.com

Phone514-331-7440

Employees48

Debt

Debt-to-Equity Ratio565.41

Current Ratio0.75

Quick Ratio0.65

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesC$822,000.00

Price / Sales43.59

Cash FlowC$0.01 per share

Price / Cash Flow23.57

Book ValueC$0.00 per share

Price / Book-325.00

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares110,260,000

Market CapC$35.83 million

Next Earnings Date3/25/2021 (Estimated)

OptionableNot Optionable

C$0.32

+0.01 (+1.56 %)

(As of 01/22/2021 02:16 PM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive IGX News and Ratings via Email

Sign-up to receive the latest news and ratings for IGX and its competitors with MarketBeat's FREE daily newsletter.

IntelGenx Technologies Corp. (IGX.V) (CVE:IGX) Frequently Asked Questions

How has IntelGenx Technologies Corp. (IGX.V)'s stock price been impacted by COVID-19?

IntelGenx Technologies Corp. (IGX.V)'s stock was trading at C$0.54 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, IGX shares have decreased by 39.8% and is now trading at C$0.33.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than IntelGenx Technologies Corp. (IGX.V)?

Wall Street analysts have given IntelGenx Technologies Corp. (IGX.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but IntelGenx Technologies Corp. (IGX.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is IntelGenx Technologies Corp. (IGX.V)'s next earnings date?

IntelGenx Technologies Corp. (IGX.V) is scheduled to release its next quarterly earnings announcement on Thursday, March 25th 2021.
View our earnings forecast for IntelGenx Technologies Corp. (IGX.V).

How were IntelGenx Technologies Corp. (IGX.V)'s earnings last quarter?

IntelGenx Technologies Corp. (IGX.V) (CVE:IGX) announced its earnings results on Thursday, November, 12th. The company reported ($0.01) EPS for the quarter. The business earned $0.68 million during the quarter.
View IntelGenx Technologies Corp. (IGX.V)'s earnings history.

Who are some of IntelGenx Technologies Corp. (IGX.V)'s key competitors?

Some companies that are related to IntelGenx Technologies Corp. (IGX.V) include ImmunoPrecise Antibodies Ltd. (IPA.V) (IPA), Scancell Holdings plc (SCLP.L) (SCLP), Medigene AG (MDG1.F) (MDG1), Ampliphi Biosciences (APHB), Antibe Therapeutics Inc. (ATE.V) (ATE), Verona Pharma plc (VRP.L) (VRP), Circassia Group Plc (CIR.L) (CIR), Acasti Pharma Inc. (ACST.V) (ACST), e-therapeutics plc (ETX.L) (ETX), Novoheart (NVH), OKYO Pharma Limited (OKYO.L) (OKYO), Oxford BioDynamics Plc (OBD.L) (OBD), C4X Discovery Holdings plc (C4XD.L) (C4XD), Agronomics Limited (ANIC.L) (ANIC) and Annovis Bio (ANVS).
View all of IGX's competitors.

What other stocks do shareholders of IntelGenx Technologies Corp. (IGX.V) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IntelGenx Technologies Corp. (IGX.V) investors own include IntelGenx Technologies (IGXT), Aurora Cannabis Inc. (ACB.TO) (ACB), New Age Brands (NF), Capstone Mining Corp. (CS.TO) (CS), Hanesbrands (HBI), Tilray (TLRY), ACADIA Pharmaceuticals (ACAD), AusCann Group Holdings Ltd (AC8.AX) (AC8), Cameco (CCJ) and Baylin Technologies Inc. (BYL.TO) (BYL).

Who are IntelGenx Technologies Corp. (IGX.V)'s key executives?

IntelGenx Technologies Corp. (IGX.V)'s management team includes the following people:

Dr. Horst G. Zerbe, Chairman, CEO & Chairman of Scientific Advisory Board (Age 73, Pay $233.65k)
Dr. Dana Matzen, VP of Bus. & Corp. Devel. (Age 42, Pay $166.19k)
Ms. Nadine Paiement, Vice-Chair of Scientific Advisory Board and VP of R&D - IntelGenx Corp (Age 43, Pay $135.67k)
Ms. Ingrid Zerbe, Corp. Sec. (Age 66)
Stephen Kilmer, Investor Relations Officer
Mr. Rodolphe Obeid Ph.D., VP of Operations - IntelGenx Corp (Age 40)

What is IntelGenx Technologies Corp. (IGX.V)'s stock symbol?

IntelGenx Technologies Corp. (IGX.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "IGX."

How do I buy shares of IntelGenx Technologies Corp. (IGX.V)?

Shares of IGX and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What is IntelGenx Technologies Corp. (IGX.V)'s stock price today?

One share of IGX stock can currently be purchased for approximately C$0.33.

How big of a company is IntelGenx Technologies Corp. (IGX.V)?

IntelGenx Technologies Corp. (IGX.V) has a market capitalization of C$35.83 million and generates C$822,000.00 in revenue each year. IntelGenx Technologies Corp. (IGX.V) employs 48 workers across the globe.

What is IntelGenx Technologies Corp. (IGX.V)'s official website?

The official website for IntelGenx Technologies Corp. (IGX.V) is www.intelgenx.com.

How can I contact IntelGenx Technologies Corp. (IGX.V)?

The company can be reached via phone at 514-331-7440.

This page was last updated on 1/23/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

IntelGenx Technologies Corp. (IGX.V) Stock Forecast, Price & News

Adding

Adding

Adding IntelGenx Technologies Corp. (IGX.V)

MarketRank™

Overall MarketRank™